A randomized double blind trial to compare efficacy of three different dosing schedules of itraconazole for the treatment of tinea corporis and cruris.
Not Applicable
Completed
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2020/03/024326
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 149
Inclusion Criteria
180 consenting adult patients with a diagnosis of Tinea cruris and/or corporis, on clinical examination with confirmation by KOH microscopy, who would require systemic treatment as per the assessment of the examining physician.
Exclusion Criteria
a) Those on any regular systemic drug or with any pre-existing systemic disease.
b) Those with history of drug induced hepatotoxicity or ventricular dysfunction.
c) Those with deranged baseline liver function tests.
d) Those with a history of a hypersensitivity reaction to itraconazole before.
e) Pregnant and lactating females.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method